Cargando…
BRD4 regulates key transcription factors that drive epithelial-mesenchymal transition in castration-resistant prostate cancer
BACKGROUND: Androgen deprivation therapies for the hormone-dependent stages of prostate cancer have become so effective that new forms of chemoresistant tumors are emerging in clinical practice, and require new targeted therapies in the metastatic setting. Yet there are important gaps in our underst...
Autores principales: | Shafran, Jordan S., Jafari, Naser, Casey, Allison N., Győrffy, Balázs, Denis, Gerald V. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7855805/ https://www.ncbi.nlm.nih.gov/pubmed/32690869 http://dx.doi.org/10.1038/s41391-020-0246-y |
Ejemplares similares
-
PCAF‐mediated acetylation of ISX recruits BRD4 to promote epithelial‐mesenchymal transition
por: Wang, Li‐Ting, et al.
Publicado: (2020) -
Digitoxin Inhibits Epithelial-to-Mesenchymal-Transition in Hereditary Castration Resistant Prostate Cancer
por: Pollard, Bette S., et al.
Publicado: (2019) -
Contributions of epithelial-mesenchymal transition and cancer stem cells to the development of castration resistance of prostate cancer
por: Li, Ping, et al.
Publicado: (2014) -
The Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player?
por: Khan, Tanzila, et al.
Publicado: (2020) -
SSX2 regulates focal adhesion but does not drive the epithelial to mesenchymal transition in prostate cancer
por: Bloom, Jordan E., et al.
Publicado: (2016)